(NASDAQ: MBOT) Microbot Medical's forecast annual revenue growth rate of 273.19% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.06%.
Microbot Medical's revenue in 2026 is $418,000.On average, 6 Wall Street analysts forecast MBOT's revenue for 2026 to be $124,926,530, with the lowest MBOT revenue forecast at $58,976,068, and the highest MBOT revenue forecast at $246,830,644. On average, 6 Wall Street analysts forecast MBOT's revenue for 2027 to be $492,385,156, with the lowest MBOT revenue forecast at $148,098,386, and the highest MBOT revenue forecast at $775,753,452.
In 2028, MBOT is forecast to generate $1,603,089,470 in revenue, with the lowest revenue forecast at $1,388,833,755 and the highest revenue forecast at $1,911,174,412.